Cargando…
Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition
Context: This article reviews the use of albumin microcapsules 3–4 mm in size containing cytokine inhibiting drugs which include neutralizing antibodies to TNF and IL1, CNI-1493, antisense oligonucleotides to TNF and NF-kappaB, and the antioxidant catalase. Objective: Describe the effects, cellular...
Autores principales: | Oettinger, Carl W., D'Souza, Martin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433085/ https://www.ncbi.nlm.nih.gov/pubmed/22348221 http://dx.doi.org/10.3109/02652048.2012.658443 |
Ejemplares similares
-
Microencapsulation: A promising technique for controlled drug delivery
por: Singh, M.N., et al.
Publicado: (2010) -
Inhibition of Pro-Inflammatory Cytokines by Metabolites of Streptomycetes—A Potential Alternative to Current Anti-Inflammatory Drugs?
por: Hrdý, Jiří, et al.
Publicado: (2020) -
Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation
por: Urbanska, Aleksandra Malgorzata, et al.
Publicado: (2010) -
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
por: Mooranian, Armin, et al.
Publicado: (2014) -
Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation
por: Abdelbary, A., et al.
Publicado: (2012)